Greenwich LifeSciences GLSI
NASDAQ GLSI
$17.10 -0.95 (-5.24%)
As of: Oct 1, 2026 · 2:21 PM EDT

Greenwich LifeSciences (GLSI) Other Non-Current Liabilities (2024 - 2026)

Updated

Greenwich LifeSciences (GLSI) recorded Other Non-Current Liabilities of $673,819 in Q1 2026, up 120.0% from $306,281 a year earlier and unchanged from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Other Non-Current Liabilities (2024 - 2026) Analysis & Trends

Starting with Q4 2024, Greenwich LifeSciences' Other Non-Current Liabilities history includes 5 quarters.

  • Across earlier years, Other Non-Current Liabilities came in at $306,281 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Greenwich LifeSciences 264.72 Mn 264.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 673,819.00
Dec 31, 2025 673,819.00
Jun 30, 2025 306,281.00
Mar 31, 2025 306,281.00
Dec 31, 2024 306,281.00
API Access

Greenwich LifeSciences Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=GLSI&period=max&api_key=YOUR_API_KEY